Table 2.
Laboratory Measurements
| Measures | Values |
|---|---|
| Hemoglobin, g/dL | 11.5±2.0 |
| AST, IU/L | 26 (18–35) |
| ALT, IU/L | 21 (13–36) |
| γGTP, IU/L | 27 (17–40) |
| Blood urea nitrogen, mg/dL | 17 (14–23) |
| Creatinine, mg/dL | 0.96 (0.76–1.25) |
| eGFR, mL/min per 1.73 m2 | 54.5±19.3 |
| Uric acid, mg/dL | 5.6±1.6 |
| Total cholesterol, mg/dL | 141±45 |
| LDL cholesterol, mg/dL | 80±32 |
| HDL cholesterol, mg/dL | 42±11 |
| Triglycerides, mg/dL | 95 (59–126) |
| Fasting glucose, mg/dL | 106 (93–129) |
| Insulin, µU/mL | 5.1 (2.7–8.7) |
| HOMA‐R | 1.22 (0.62–3.15) |
| HbA1c, % | 6.1±1.1 |
| hs‐CRP, mg/dL | 0.14 (0.06–0.31) |
| NT‐proBNP, pg/mL | 288 (104–1004) |
Variables are expressed as means±SD or medians (interquartile ranges). ALT indicates alanine transaminase; AST, aspartate transaminase; eGFR, estimated glomerular filtration rate; γGTP, γ‐glutamyl transpeptidase; HbA1c, hemoglobin A1c; HDL, high‐density lipoprotein; HOMA‐R, homeostasis model assessment of insulin resistance; hs‐CRP, high‐sensitivity C‐reactive protein; LDL, low‐density lipoprotein; and NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.